SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-22-004440
Filing Date
2022-02-09
Accepted
2022-02-09 17:25:43
Documents
16
Effectiveness Date
2022-02-09

Document Format Files

Seq Description Document Type Size
1 S-8 vktx-s8.htm S-8 98654
2 EX-FILING FEES vktx-exfilingfees_8.htm EX-FILING FEES 19237
3 EX-5.1 vktx-ex51_6.htm EX-5.1 26824
4 EX-23.1 vktx-ex231_7.htm EX-23.1 3306
5 GRAPHIC gqbxor1oy153000002.jpg GRAPHIC 631
6 GRAPHIC gqbxor1oy153000008.jpg GRAPHIC 970
7 GRAPHIC gqbxor1oy153000006.jpg GRAPHIC 635
8 GRAPHIC gqbxor1oy153000012.jpg GRAPHIC 631
9 GRAPHIC gqbxor1oy153000005.jpg GRAPHIC 970
10 GRAPHIC gqbxor1oy153000004.jpg GRAPHIC 635
11 GRAPHIC gqbxor1oy153000010.jpg GRAPHIC 635
12 GRAPHIC gqbxor1oy153000007.jpg GRAPHIC 647
13 GRAPHIC gqbxor1oy153000011.jpg GRAPHIC 631
14 GRAPHIC gqbxor1oy153000003.jpg GRAPHIC 639
15 GRAPHIC gqbxor1oy153000001.jpg GRAPHIC 631
16 GRAPHIC gqbxor1oy153000009.jpg GRAPHIC 635
  Complete submission text file 0001564590-22-004440.txt   162353
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262609 | Film No.: 22608406
SIC: 2834 Pharmaceutical Preparations